Difference between revisions of "ATC code L"
From Self-sufficiency
m (Category) |
m |
||
| Line 13: | Line 13: | ||
[[Category:ATC codes|L]] | [[Category:ATC codes|L]] | ||
[[Category:Antineoplastic and immunomodulating drugs| ]] | [[Category:Antineoplastic and immunomodulating drugs| ]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
Latest revision as of 18:21, 27 September 2011
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QL...[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| L Antineoplastic and immunomodulating agents |
|---|
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology.
